Credit Suisse analyst Sayantan Maji downgraded Dr. Reddy’s to Underperform from Neutral with a INR 4,000 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RDY: